(Q59120493)
Statements
Onercept for moderate-to-severe Crohn's disease: a randomized, double-blind, placebo-controlled trial (English)
William J Sandborn
Paul Rutgeerts
Daniel Rachmilewitz
Dino Tarabar
Peter Gibson
Ole Haagen Nielsen
Stefan Schreiber
Claudia Pena Rossi
Monia Zignani
Onercept Study Group